1. |
αA (adipose tissue volume) |
15.60 L |
2. |
αL (liver tissue volume) |
1.60 L |
3. |
αM (skeletal muscle volume) |
26.4 L |
4. |
β6 (rate of liver de novo lipogenesis from pyruvate) |
31.6 L/min |
6. |
βf (adipose release of triacylglycerides to non-esterified fatty acids) |
0.117 mmol/min |
7. |
βL (liver glycogenolysis) |
12 L/min |
8. |
βm (muscle glycogenolysis) |
82.5 L/min |
9. |
µamp (national adenosine monophosphate/adenosine diphosphate creation rate) |
1.8 |
10. |
µb (lactate production by red blood cells) |
0.133 mmol/min |
11. |
µe (muscle triglyceride breakdown to free fatty acids) |
0.420 mmol/min |
12. |
µs (muscle free fatty acid esterification to triglycerides) |
7.19 × 106 L mmol/min |
13. |
µ1 (plasma glucose usage) |
0.588 mmol/min |
14. |
µ3 (muscle glucose-6-phospahte usage) |
7.839 × 107 L mmol/min |
15. |
µ4 (muscle free fatty acid usage) |
100 L/min |
16. |
c0 (small parameters) |
0.1 mmol/L |
17. |
cc (range of glucose concentrations over which excess insulin secretion occurs) |
2.5 mmol/L |
18. |
dba (adipose uptake of glucose) |
0.3 mmol/min |
19. |
k10 (affinity for hydrolysis of triglycerides to secretory pool) |
0.625 mmol/L |
20. |
k11 (basal insulin secretion rate) |
48 mmol/min |
21. |
k12 (increased fraction of very low-density lipoprotein 1 secretion by insulin) |
0.2 |
22. |
k13 (rate at which insulin modifies the fraction of very low-density lipoprotein 1 to very low-density lipoprotein 2 secretion) |
15 mmol/L |
23. |
k14 (basal very low-density lipoprotein 1 secretion fraction) |
0.6 |
24. |
k22 (excess insulin secretion rate due to glucose stimulation) |
48 mmol/min |
25. |
k5 (flux control coefficient for insulin inhibition of free fatty acid oxidation) |
8.23 × 107/mmol |
26. |
k6 (affinity for very low-density lipoprotein 2 triglyceride secretion through secretory pathway) |
0.3 mmol/L |
27. |
k61 (liver glucose dephosphorylation rate) |
4 L/min |
28. |
k6p (muscle glucose-6-phospahte to pyruvate conversion rate) |
6.56 × 108 L2/mmol min |
29. |
k7 (maximum rate of free fatty acid oxidation) |
0.759 L/min |
30. |
k8 (affinity for esterification of free fatty acids to triglycerides) |
0.625 mmol/L |
31. |
k9 (affinity of additional bulk lipidation) |
43.583 mmol/L |
32. |
k9a (release of very low-density lipoproteins from secretory pathway) |
1 L/min |
33. |
ka (adipose free fatty acid uptake of chylomicron triglycerides, insulin independent) |
0.1497 L/min |
34. |
kaa (adipose free fatty acid esterification to triglycerides) |
3.11 × 105 L2/mmol min |
35. |
kai (adipose free fatty acid uptake of chylomicron triglycerides, insulin dependent) |
2.08 × 106 1/mmol |
36. |
kal (pyruvate to acetyl coenzyme A conversion rate) |
0.00002 L2/mmol min |
37. |
kba (adipose uptake of endogenous lipoprotein triglycerides) |
0.0104 L/min |
38. |
kbl (liver uptake of plasma non-esterified fatty acids) |
0.156 L/min |
39. |
kbm (muscle uptake of plasma non-esterified fatty acids) |
0.226 L/min |
40. |
kcl (liver free fatty acid uptake of chylomicron triglycerides) |
0.0075 L/min |
41. |
kcm (muscle free fatty acid uptake of chylomicron triglycerides) |
0.0449 L/min |
42. |
kd (insulin degradation rate) |
1.733 × 1014 L/mmol |
43. |
kdl (liver glycogenolysis; insulin-inhibited rate) |
3.5 × 188 mmol/L |
44. |
kdy (muscle glycogenolysis; insulin-inhibited rate) |
4 × 108 L/mmol |
45. |
kft (adipose release of triglyceride to non-esterified fatty acids; insulin-inhibited rate) |
1.67 × 1014 L/mmol |
46. |
kga (rate of glucose diffusion between plasma and adipose mediated by glucose 4 transporters) |
1.67 × 106
|
47. |
kgi (glucose diffusion between plasma and muscles, insulin-mediated) |
2.632 × 108 mmol/L |
48. |
kgl (plasma glucose diffusion rate to liver) |
0.9277 mmol/L |
49. |
kgl2 (live glucose diffusion rate to blood) |
0.396 mmol/L |
50. |
kgm (plasma glucose diffusion rate to muscle) |
0.0380 mmol/L |
51. |
kgm2 (muscle glucose diffusion rate to plasma) |
0.0380 mmol/L |
52. |
kgp (glucose-6-phospahte uptake from adipose glycerol) |
0.311 L/min |
53. |
klp (rate of plasma triglyceride uptake by adipose tissue) |
0.25 |
54. |
kLG (Michaelis–Menten constant of glucokinase in liver) |
8.95 mmol/L |
55. |
kLH (Michaelis–Menten constant of hexokinase in liver) |
0.0115 mmol/L |
56. |
kMH (Michaelis–Menten constant of hexokinase in muscle) |
8.98 mmol/L |
57. |
kna (rate of plasma free fatty acid uptake into adipose free fatty acids) |
0.0697 L/min |
58. |
kp (rate of insulin-mediated glucose-6-phoshate to pyruvate) |
1.41 × 107 mmol/L |
59. |
kp6 (constant of pyruvate conversion to glucose-6-phospate) |
6.56 × 108 L2/mmol min |
60. |
kpp (rate of muscle pyruvate transport to liver) |
0.5 |
61. |
kr (rate of endogenously derived lipoprotein triglycerides by liver as free fatty acids) |
0.00058 mmol |
62. |
krep (glucose-6-phospahte inhibition constant of hexokinase in muscle) |
2.98 mmol/L |
63. |
kt (uptake rate of plasma endogenous triglycerides into muscle free fatty acids) |
0.00348 mmol/L |
64. |
kyl (rate of the glycogen synthesis stimulated by insulin) |
1.28 × 106
|
65. |
kym (glycogen synthesis rate) |
21.3641 mmol/L |
66. |
lmax (maximum glycogen store of liver) |
400 mmol |
67. |
mmax (maximum glycogen concentration) |
100 mmol |
68. |
v (rate of glycogen transport) |
7 mmol |
69. |
v10 (rate of triglyceride storage conversion to free fatty acids) |
0.1 mmol/min |
70. |
v12 (constant in triglyceride release into plasma) |
40 mmol L−1
|
71. |
v6 (rate of liver free fatty acid input to secretory pool) |
0.0158 mmol/L |
72. |
v8 (rate of free fatty acid input to storage pool) |
0.333 mmol/min |
73. |
v9 (rate of triglyceride release into plasma)) |
0.0159 mmol/L |
74. |
vLG (maximum rate of glucokinase in liver) |
14.3 mmol/min |
76. |
vLH (maximum rate of hexokinase in liver) |
5.57 mmol/min |
76. |
vMH (muscle hexokinase maximum rate) |
54.288 mmol/min |
77. |
y0 (range of liver glycogen concentration over which the release drops to zero) |
0.1 |
78. |
αG (rate of glucose change in diet) |
2 mmol |
79. |
αF (rate of fructose change in diet) |
2 mmol/L |
80. |
ms (insulin-dependent rate of skeletal muscle storage of free fatty acids in the form of triglycerides) |
0.8 |
81. |
me (rate of skeletal muscle triglyceride breakdown to free fatty acids) |
0.9 |